Search for: "In re Lilly" Results 21 - 40 of 785
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2009, 12:43 pm
Updating earlier ILB entries re Lilly's Zyprexa, the WSJ Law Blog has this entry, referencing this NYT report today by... [read post]
29 Jan 2009, 9:12 am
Earlier today, President Obama welcomed Lilly Ledbetter to the White House and signed the Lilly Ledbetter Fair Pay Act. [read post]
26 Dec 2006, 10:56 pm
  They cited In re Petering, 301 F.2d 676 (CCPA 1962), and In re Schaumann, 572 F.2d 312 (CCPA 1987), to support their argument. [read post]
27 Aug 2010, 7:07 am by Carey, Danis & Lowe
At the same time, the FDA isn't the only one responsible for making sure patients know what they're getting into. [read post]
20 Dec 2017, 4:42 pm
At noon on Monday, December 5, 2016, Lillie called 911 when she could not wake Leah. [read post]
15 Aug 2013, 8:41 am
 As a result, patients stopped re-filling their Byetta prescriptions and sales of Byetta were poor. [read post]
16 Nov 2015, 5:14 pm by Lawrence B. Ebert
The invention is defined by the claims, not by the disclosure.A related issue arose “In re ‘639 patent” as to prior art, which recited a synthetic pathway to a claimed compound [nabumetone] but which pathway contained an error [ironically because of reliance on a Lilly publication that was in error]. [read post]
29 Jan 2009, 10:00 am
A step in the right direction: President Obama has signed the Lilly Ledbetter Fair Pay Act, re gender pay, the first piece of legislation he has signed as president. [read post]
25 Sep 2008, 8:42 pm
Lilly will disclose payments above $500 made in 2009, but will not make disclosure about payments in past years. [read post]
24 Mar 2010, 10:00 am by Kashmir Hill
She’s an in-house attorney, who remembered Lillie’s being her suggestion for the venue. [read post]
21 Jul 2014, 10:32 am
”Even here, however, we see signs that UK courts are trying to be more consistent with the EPO, and in the HGS v Lilly litigation, reading the decision of the Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 (see IPKat here) it is possible discern in the judgment a desire to not only apply the jurisprudence of the EPO Boards of Appeal, but also to reach the same conclusion (of sufficiency of the claims) on the specific facts of the… [read post]
30 Jun 2015, 8:59 am by James T. Kittrell
  In exchange, Kachina would pay Lillis a percentage of the re-sale price it obtained from Davis. [read post]
30 Jun 2015, 8:59 am by James T. Kittrell
  In exchange, Kachina would pay Lillis a percentage of the re-sale price it obtained from Davis. [read post]
23 Dec 2011, 3:04 pm by Danielle Citron
(When you’re facing Conn from the hotel, turn left.) [read post]
11 Dec 2009, 11:47 am
Eli Lilly & Co., 2009 WL 4768195, slip op. [read post]